Case study

Assessment of the perceived value of two PCV-20 pediatric vaccines and the possible P&MA outcomes in public and private market setting

Client Situation

Our client, a leading infectious disease vaccine manufacturer, sought to understand the current recommendation process for adult pneumococcal vaccines in key markets, identify unmet needs, assess payer and VTC value perceptions, price potential and applicable funding pathways for two new PCV-20 vaccines. Additionally, they explored the impact of vaccine launch sequence on the price potential

flag_image

Project Scope

    Evaluating the value drivers and pricing potential for two paediatric PCV vaccines, and understanding likelihood of achieving access via public funding in both the Kingdom of Saudi Arabia and in South Africa

Focus Markets

flag_image

Solutions

    We conducted extensive primary research to get detailed insights on:

  • Contributing factors to the unmet need in the PCV space for the markets in scope
  • Applicable funding pathways for both PCV vaccines as well as graded level of impact of various clinical outcomes on payer/physician willingness to pay
  • Value perception and price expectations for the two vaccines in both the private and the public market setting
flag_image

Results

  • Successfully enabled our client to understand considerations that influence the adoption and pricing of PCV vaccines in the public and private market
  • Recommended likely price points at which patients would be willing to purchase out of pocket